Neoadjuvant pembrolizumab and chemotherapy in resectable clinical stage III non-small-cell lung cancer: a retrospective cohort study
Guangyin Zhao(Shanghai Medical College of Fudan University), Di Ge(Nanjing University of Information Science and Technology), Chunlai Lu(Zhongshan Hospital), Jie Gu(Tongji University), Teng Ma(Fudan University), Hongyu Zhang(Dongguan People’s Hospital), Qiaoliang Zhu(Sun Yat-sen University), Fengkai Xu(Zhongshan Hospital), Duilio Divisi(University of L'Aquila), Francesco Grossi(University of Insubria)
Cited by 12
Related Papers
Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2010|454
Targeting gut microbiota and metabolism as the major probiotic mechanism - An evidence-based review
|Trends in Food Science & Technology|2023|286
Whole-genome sequencing of six dog breeds from continuous altitudes reveals adaptation to high-altitude hypoxia
|Genome Research|2014|227